Transamerica Financial Advisors Inc. lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 12.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,997 shares of the exchange traded fund’s stock after selling 973 shares during the quarter. Transamerica Financial Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $692,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also modified their holdings of the business. Tidemark LLC grew its holdings in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $44,000. Finally, Howe & Rusling Inc. acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $49,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $98.80 on Wednesday. The stock’s 50-day moving average is $98.37 and its 200-day moving average is $96.38. The company has a market cap of $7.53 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $71.99 and a 52-week high of $105.47.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Gold vs. Silver: Profit Opportunities in the Widening Spread
- Why Invest in 5G? How to Invest in 5G Stocks
- Semler Stock Surges Over 130% in November: A New Bitcoin Play?
- 3 Monster Growth Stocks to Buy Now
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.